Posted in | News | Imaging | Medical Optics

Optical Coherence Tomography Platform for Intravascular Lesion Assessment

Medical device company, St. Jude Medical will showcase its new Optical Coherence Tomography (OCT) solution at the 22nd Transcatheter Cardiovascular Therapeutics annual meeting, in Washington, D.C.

C7-XR OCT Intravascular Imaging System

The C7-XR OCT Intravascular Imaging System complements St. Jude Medical’s PressureWire Fractional Flow Reserve (FFR) measurement technology platform, providing new standard for complete intravascular lesion diagnosis.

The C7-XR OCT System helps physicians in treating cardiovascular disease. It utilizes near-infrared light to generate high-resolution images. These images enable physicians to visualize and calculate vital vessel characteristics. The C7-XR OCT platform adds anatomical information to the physiological data offered by FFR measurements. The FFR precisely recognizes stent and lesions. The OCT-guided treatment is significant for stent placement examination, as it accurately indicates the position of the stent against the artery wall.

The C7-XR System also offers physicians with post-stenting data by analyzing the stent’s deployment and position. The OCT technology offers complete information related to the vessel’s inner lining. In addition, the technology provides information regarding the reappearance of the narrowing of blood vessels.

Source: http://www.sjm.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.